Rhinovirus Study With Lactobacillus Rhamnosus GG

NCT01229917 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2011-07-07

No results posted yet for this study

Summary

The purpose of this study is to evaluate the symptom impact of probiotic Lactobacillus rhamnosus GG during rhinovirus infection.

Conditions

  • Respiratory Tract Infections [C08.730]

Interventions

OTHER

Fruit juice with Lactobacillus rhamnosus GG, version 1

OTHER

Fruit juice with Lactobacillus rhamnosus GG, version 2

OTHER

Standard fruit juice

Sponsors & Collaborators

  • University of Helsinki

    collaborator OTHER
  • University of Virginia

    collaborator OTHER
  • Medcare Ltd

    collaborator UNKNOWN
  • Valio Ltd

    lead INDUSTRY

Principal Investigators

  • Birgit Winther, Dr. · University of Virginia Health System

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01229917 on ClinicalTrials.gov